Search research articles
Contact Us
Filters
Showing results (81-90 of 145) with videos related to
Page
of 15
Sort By:
The American Journal of Cardiology
|
December 13, 2000
Both atenolol and propranolol blunt the fibrinolytic response to exercise but not resting fibrinolytic potential
B Fernhall, L M Szymanski, P A Gorman, et al.
Blood
|
July 15, 1995
A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin
R S Schwartz, D A Gabriel, L M Aledort, et al.
British Journal of Haematology
|
January 1, 1985
IgA inhibitor to factor VIII/von Willebrand factor
H R Gralnick, M A Flaum, C M Kessler, et al.
Thrombosis and Haemostasis
|
May 1, 1995
Catalyzing global access to hemophilia care
C M Kessler, G A Gellert, G Mariani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2011
Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008)
E J Neufeld, C M Kessler, J C Gill, et al.
American Journal of Hematology
|
September 1, 1991
Skin necrosis following prolonged administration of coumarin in a patient with inherited protein S deficiency
S L Goldberg, C L Orthner, B L Yalisove, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 18, 2015
Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment
S R Earnshaw, C N Graham, C L McDade, et al.
JAMA
|
June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy
G F Pierce, J M Lusher, A P Brownstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 2, 2002
Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII
P L F Giangrande, C M Kessler, C E Jenkins, et al.
American Journal of Obstetrics and Gynecology
|
October 16, 1999
Hemostatic responses to maximal exercise in oral contraceptive users
R Otterstetter, L M Szymanski, G H Kamimori, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 145) with videos related to
Sort By:
Page
of 15
The American Journal of Cardiology
|
December 13, 2000
Both atenolol and propranolol blunt the fibrinolytic response to exercise but not resting fibrinolytic potential
B Fernhall, L M Szymanski, P A Gorman, et al.
Blood
|
July 15, 1995
A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin
R S Schwartz, D A Gabriel, L M Aledort, et al.
British Journal of Haematology
|
January 1, 1985
IgA inhibitor to factor VIII/von Willebrand factor
H R Gralnick, M A Flaum, C M Kessler, et al.
Thrombosis and Haemostasis
|
May 1, 1995
Catalyzing global access to hemophilia care
C M Kessler, G A Gellert, G Mariani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2011
Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008)
E J Neufeld, C M Kessler, J C Gill, et al.
American Journal of Hematology
|
September 1, 1991
Skin necrosis following prolonged administration of coumarin in a patient with inherited protein S deficiency
S L Goldberg, C L Orthner, B L Yalisove, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 18, 2015
Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment
S R Earnshaw, C N Graham, C L McDade, et al.
JAMA
|
June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy
G F Pierce, J M Lusher, A P Brownstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 2, 2002
Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII
P L F Giangrande, C M Kessler, C E Jenkins, et al.
American Journal of Obstetrics and Gynecology
|
October 16, 1999
Hemostatic responses to maximal exercise in oral contraceptive users
R Otterstetter, L M Szymanski, G H Kamimori, et al.
Page
of 15